Drugs and Treatments for Autoimmune Diseases: Global Markets
The global market for autoimmune treatments reached at $34 billion in 2010, it is expected to reach at $38.9 billion by 2011 and it will further grow to $55 billion by 2016 at a compounded annual growth rate (CAGR) of 7.2%.
SCOPE OF REPORT
This report offers forecasts by product segment, disease, and geographical region from 2011 through 2016, including supporting analyses for projections.
This report is a valuable tool for anyone assessing the autoimmune market and attempting to devise a strategy for successful competition within it. It provides a thorough background on the structure of the autoimmune market and the chief challenges and opportunities it faces. It offers the information necessary for understanding the current market and for addressing the emerging one.
Peggy S. Lehr is the BCC Research Analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder and an MS in Communication from the University of Denver. Ms. Lehr has completed more than 13 reports for BCC, primarily on the medical and pharmaceutical industries. She has worked within the publishing industry for both for-profit and not-for-profit organizations.